At HBH, our mission is to work together as a team with our patients, colleagues, and local community resources to design an effective treatment plan. We know that struggling with mental health can be a difficult and painful journey, which is why we work very hard to make your experience at HBH as seamless and as positive as possible.
NeuroStar TMS is a non-drug, noninvasive treatment that uses focused magnetic fields to revitalize underactive areas of the brain to improve symptoms of depression. NeuroStar is a safe, effective depression treatment for people who have not found relief from antidepressants.
Afolarin Banjoko, MD, is a graduate of the College of Medicine, University of Lagos, Lagos, Nigeria where he received a Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) degree. His education in Psychiatry started with three years of training in the United Kingdom. He completed three years of residency in Psychiatry at Howard University Hospital, Washington, D.C. and 15 months of fellowship in Child and Adolescent Psychiatry at The Children’s Hospital of Philadelphia. Dr. Banjoko has over 25 years of experience treating mental health disorders in patients of all ages and specializes in general adult, child, and adolescent psychiatry.
In his free time, he enjoys traveling extensively and spending time with his family and friends.
83% of patients completing NeuroStar treatment experienced measurable depression relief, and 62% experienced full remission of their depression symptoms.
Spravato is the brand name for esketamine, a medication used to treat treatment-resistant depression.
It is administered as a nasal spray and can be effective in reducing symptoms of depression, even in patients who have not responded to other forms of treatment.
it can rapidly improve symptoms, even in individuals who have not responded to other forms of treatment.
